Teva's earnings May 7th - sec.gov/cgi-bin/browse-edgar?CIK=teva&owner=exclude&action=getcompany

Weekly chart is flashing buy signals with the 50SMA Crossing back under the price.

Unknowns: COVID-19 impact on TEVA earnings

Decision - Wait until after earnings to get in, still to many unknowns.

The reason I like TEVA : Possible Turn-around play, looking for teva to turn net-loss to net-profit in the coming years if they continue to lower debt and start turning profit.

Earnings (loss) per share attributable to ordinary shareholders:
Basic ($)
2020 - Lower?
2019 - (0.91) even lower?
2018 - (2.35) Lower loss
2017 - (16.26) Huge loss
2016 - 0.07 Smaller profit
2015 - 1.84 Profit

Diluted ($)
2019 - (0.91)
2018 - (2.35)
2017 - (16.26)
2016 - 0.07
2015 -1.82

https://www.sec.gov/ix?doc=%2FArchives%2Fedgar%2Fdata%2F818686%2F000119312520044221%2Fd852939d10k.htm

biotechFibonacciFundamental AnalysispharaceuticalsPHARMATEVAtevapharmaceuticalTrend Lines

Also on:

Related publications

Disclaimer